Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability (2012)
- Authors:
- USP affiliated authors: BENDHACK, LUSIANE MARIA - FCFRP ; GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FCFRP; FORP; FMRP
- DOI: 10.1016/j.niox.2012.01.009
- Subjects: HIPERTENSÃO; FÁRMACOS (SISTEMA CARDIOVASCULAR) (EFEITOS); ESTRESSE OXIDATIVO; NEUTRÓFILOS (TESTES;TÉCNICAS IN VITRO)
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2012
- Source:
- Título: Nitric Oxide
- ISSN: 1089-8603
- Volume/Número/Paginação/Ano: v. 26, n. 3, p. 162-168, 2012
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CASTRO, Michele M. et al. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide, v. 26, n. 3, p. 162-168, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2012.01.009. Acesso em: 07 maio 2026. -
APA
Castro, M. M., Rizzi, E., Ceron, C. S., Guimarães, D. A., Rodrigues, G. J., Bendhack, L. M., et al. (2012). Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide, 26( 3), 162-168. doi:10.1016/j.niox.2012.01.009 -
NLM
Castro MM, Rizzi E, Ceron CS, Guimarães DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability [Internet]. Nitric Oxide. 2012 ; 26( 3): 162-168.[citado 2026 maio 07 ] Available from: https://doi.org/10.1016/j.niox.2012.01.009 -
Vancouver
Castro MM, Rizzi E, Ceron CS, Guimarães DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability [Internet]. Nitric Oxide. 2012 ; 26( 3): 162-168.[citado 2026 maio 07 ] Available from: https://doi.org/10.1016/j.niox.2012.01.009 - Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings
- Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
- Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats
- Increased activity of matrix metalloproteinase-2(MMP-2) induced by reactive oxygen species (ROS) in two-kidney one-clip (2K1C) hypertension
- Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
- Metalloproteinase inhibition ameliorates hypertension and reverses vascular dysfunction and remodeling in renovascular hypertensive rats
- Evaluation of aortic metalloproteinase-2 (MMP-2) activity in two kidney one clip (2K1C) hypertension rats
- Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
- Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
